Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Poalim Capital Markets is an Israel-based investment banking and merchant banking firm affiliated with Bank Hapoalim and commonly branded today as Poalim Equity. The firm provides M&A advisory, private placements, public offerings, valuations, restructurings, and private equity investment services across multiple sectors. It is not a biotech, pharma, or healthcare operating company and does not appear to develop therapeutic products or maintain a clinical pipeline. Its healthcare relevance is indirect, through advisory and investment activity that may include healthcare or pharmaceutical transactions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Poalim Capital Markets.